HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sheng Teng Selected Research
Sheng Teng Research Topics
Disease
7
Sarcoma (Soft Tissue Sarcoma)
01/2024 - 05/2017
5
Neoplasms (Cancer)
01/2024 - 05/2017
3
Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 01/2019
1
Melanoma (Melanoma, Malignant)
11/2022
1
Growth Disorders
10/2020
1
Disease Resistance
10/2019
1
Genomic Instability
10/2019
1
Hepatocellular Carcinoma (Hepatoma)
05/2018
1
Stomach Neoplasms (Stomach Cancer)
05/2018
1
Breast Neoplasms (Breast Cancer)
05/2018
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2018
1
Shock
02/2018
Drug/Important Bio-Agent (IBA)
4
apatinib
IBA
02/2020 - 05/2018
2
RNA (Ribonucleic Acid)
IBA
11/2022 - 10/2019
2
endostar protein
IBA
01/2021 - 05/2017
2
Endostatins
IBA
01/2021 - 05/2017
1
Cholesterol
IBA
11/2022
1
Transforming Growth Factor beta (TGF-beta)
IBA
11/2022
1
Interferon Type I
IBA
11/2022
1
Biomarkers (Surrogate Marker)
IBA
11/2021
1
Sucrose (Saccharose)
IBA
10/2020
1
Doxorubicin (Adriamycin)
FDA Link
Generic
02/2020
1
Retroelements (Retrotransposon)
IBA
10/2019
1
Tyrosine Kinase Inhibitors
IBA
05/2018
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
05/2018
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
05/2018
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
05/2018
Therapy/Procedure
5
Drug Therapy (Chemotherapy)
01/2021 - 05/2017
3
Therapeutics
11/2021 - 05/2018
1
Immunotherapy
01/2024
1
Combination Drug Therapy (Combination Chemotherapy)
01/2019
1
Investigational Therapies (Experimental Therapy)
05/2018
1
Transplantation
02/2018